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1. Introduction 
Teledermatology is defined as the provision of dermatologic care through the use of 
communications technology (Goldyne & Armstrong, 2010). It offers many benefits that 
include increased access to dermatologic services and potential reduction in costs associated 
with care. Teledermatology is traditionally categorized into two different models based on 
the technology that is employed: store-and-forward (S&F) teledermatology, and live, 
interactive (LI) teledermatology (Goldyne & Armstrong, 2010). While hybrid models (a 
combination of S&F and LI technology) are practiced at selected institutions, this chapter 
focuses primarily on S&F and LI models. We will present operational flows of these two 
technology-enabled modalities, common outcomes measures used for evaluation of 
teledermatology quality metrics, and economic analyses.  
At the end of the chapter (in section 5), we will consider a novel, technology-independent 
framework for categorizing teledermatology models as well. This system relies on 
classification of teledermatology based on healthcare delivery models, and serves as an 
alternative way to organize and evaluate the provision of teledermatologic care. 
2. Store-and-forward teledermatology 
Store-and-forward teledermatology is an asynchronous means for providing dermatologic 
care, as it relies on the asynchronous transmission of static digital images, patient histories, 
and specialist recommendations rather than real-time interaction between the specialist and 
the patient (Goldyne & Armstrong, 2010). 
In the S&F model, a medical staff personnel at the referral site typically takes images of the 
relevant skin condition and obtains medical history. This information is then sent to a 
dermatologist via a secure internet connection. The dermatologist evaluates the patient’s 
condition asynchronously and transmits the recommendations back to the primary care 
provider at the referral site (Pak et al., 2009).  
2.1 Outcomes measures of store-and-forward teledermatology 
Teledermatology studies have assessed numerous outcomes measures, including learning 
effects, length of consultation, and technical aspects (Eminovic et al., 2007). We will focus 
this discussion on four extensively used outcomes measures: diagnostic accuracy, diagnostic 
reliability, clinical outcomes, and satisfaction. 
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2.1.1 Diagnostic accuracy of store-and-forward teledermatology 
Diagnostic accuracy refers to whether or not a diagnosis is correct, based on comparison to a 
gold standard reference test. While histopathological review or other laboratory tests are 
often used as the gold standard for diagnosis, results of these types of gold standards are 
not always available in clinical practice in dermatology. Furthermore, it is difficult to 
generate cumulative data regarding accuracy, because different studies use different 
methodologies and standards.   
Several studies have found diagnostic accuracy of S&F teledermatology to be comparable to 
in-person consultations (Barnard & Goldyne 2000; High et al., 2000; Krupinski et al., 1999; 
Oakley et al., 1997; Whited et al., 1999). Other studies have found that in-person consultation 
provides a significantly greater diagnostic accuracy than S&F teledermatology (Warshaw et 
al. 2009a; Warshaw et al. 2009b). One study found that S&F teledermatology had a 
significantly greater diagnostic accuracy than in-person consultation (Lozzi et al., 2007).  
Different findings on diagnostic accuracy may be attributable to several factors. First, the 
“gold standard” used among the studies differ from in-person evaluations to pathologic 
evaluation. Second, patient populations and types of skin lesions differ among the various 
practices that were examined. Future studies can focus on tools or interventions to increase 
diagnostic accuracy of S&F teledermatology, such as routine incorporation of dermoscopy 
(Warshaw et al., 2010a). 
2.1.2 Diagnostic reliability of store-and-forward teledermatology 
Diagnostic reliability is a measure of concurrence in diagnosis. It may refer to intraobserver 
reliability (whether one examiner makes the same diagnosis in two different examinations), 
or interobserver reliability (whether two different examiners make the same diagnosis). 
These measures of reliability may evaluate either complete agreement, which refers to 
comparison of the most likely diagnosis, or partial agreement, which accounts for 
differential diagnoses. 
Studies of intraobserver reliability between S&F teledermatology and in-person consultation 
found that agreement ranges between 31-88% for complete diagnostic agreement, and 
between 50-95% for partial diagnostic agreement (Table 1). 
 
Reference 
Complete Diagnostic 
Agreement 
Partial Diagnostic Agreement 
(Romero et al., 2010) .85 .92 
(Tan et al., 2010) .74 .88 
(Heffner et al., 2009) .82 - 
(Ebner et al., 2008) .74 .90 
(Pak et al., 2003) .70 .91 
(Lim et al., 2001) .88 .95 
(Taylor et al., 2001) .31-.64 .50-.70 
(Krupinski et al., 1999) - .76-.90 
Table 1. Intraobserver Reliability for S&F Teledermatology and Conventional Care 
Studies have found that interobserver reliability ranges between 41-92% for complete 
diagnostic agreement and between 51-100% for partial diagnostic agreement (Table 2). A 
review of studies between 1997 and 2005 revealed that the aggregate complete diagnostic 
agreement was 60%, and partial diagnostic agreement was 80% (Romero et al., 2008).  
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Reference 
Complete Diagnostic 
Agreement 
Partial Diagnostic Agreement 
(Tan et al., 2010) .75-.82 .83-.89 
(Heffner et al., 2009) .69 - 
(Silva et al., 2009) .87-.92 .96-1.0 
(Edison et al., 2008) .73 - 
(Ebner et al., 2008) .71-.76 .90-.97 
(Bowns et al., 2006) .55 - 
(Oakley et al., 2006) .53 .64 
(Tucker & Lewis, 2005) .56 .68 
(Baba et al., 2005) .75 - 
(Mahendran et al., 2005) .44-.48 .64-.65 
(Du Moulin et al., 2003) .54 .63 
(Eminovic et al., 2003) .41 .51 
(Lim et al., 2001) .73-.85 .83-.89 
(Taylor et al., 2001) .44-.51 .57-.61 
(High et al., 2000) .64-.77 .81-.89 
(Whited et al., 1999) .41-.55 .79-.95 
(Lyon & Harrison, 1997) .89 - 
(Zelickson & Homan, 1997) .88 - 
(Kvedar et al., 1997) .61-.64 .67-.70 
Table 2. Interobserver Reliability for S&F Teledermatology and Conventional Care 
Based on this data on diagnostic reliability, it appears that S&F teledermatology is a 
functional and reasonably reliable tool for diagnosis of skin disorders. 
2.1.3 Clinical outcomes for store-and-forward teledermatology 
To date, two studies have evaluated clinical outcomes of S&F teledermatology compared to 
conventional care, and both studies found similar outcomes for each of the two treatment 
modalities (Krupinski et al., 2004; Pak et al., 2007). Specifically, Pak et al. conducted a 
randomized controlled trial with patients randomly assigned to either conventional face-to-
face care or teledermatology. Another dermatologist, blinded to the randomization, 
evaluated the clinical outcomes between baseline data and after four months (Table 3). The 
results suggest that teledermatology and conventional care result in similar outcomes (Pak 
et al., 2007). 
 
 
Clinical Course Rating 
Improved No change Worse 
Assigned Group 
Teledermatology 64% 33% 4% 
Conventional Care 65% 32% 3% 
Table 3. Reported Clinical Outcomes from Pak et al. 
We may also consider intermediate clinical outcomes, such as (1) time-to-intervention and 
(2) preventable clinic visits. Time-to-intervention is usually defined as the wait time prior to 
being seen by a specialist after a referral has been placed. Preventable clinic visits refers to 
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the percentage of dermatology clinic visits that could be avoided through use of 
teledermatology. 
The literature suggests that the use of S&F teledermatology may considerably reduce time-
to-intervention. Researchers in Spain found that surgical patients managed through S&F 
teledermatology had a mean waiting interval 34.47 days shorter than those patients 
managed through conventional care (Ferrandiz et al., 2007). A similar study found that 
patients at primary care centers managed through teledermatology waited on average 76.31 
days less than those with conventional referrals (Moreno-Ramirez et al., 2007). A study of 
patients at the Durham VA Medical Center found that those that received a S&F 
teledermatology consultation were seen on average 86 days sooner than those in the 
conventional system (Whited et al., 2002). 
The reduced time-to-intervention may be partially due to the fact that teledermatology can 
help prevent unnecessary clinic visits. Indeed, studies have found that S&F teledermatology 
could prevent 13-58% of dermatology clinic visits (Whited, 2010).  
2.1.4 Satisfaction with store-and-forward teledermatology 
Satisfaction assessments may be subdivided into three categories: patient satisfaction, referring 
provider satisfaction, and specialist satisfaction. Studies suggest that patients were generally 
satisfied with receiving care through S&F teledermatology, and typically had no preference 
between teledermatology and usual care (Warshaw et al., 2010b). One study found that 76% of 
patients preferred being treated through teledermatology in order to avoid the wait time 
associated with a face-to-face clinic visit (Bowns et al., 2006). A common patient complaint 
during the S&F teledermatology process was the length of time between the consultation and 
being informed of the results by the primary care providers (Whited, 2010). 
When referring providers were asked about their satisfaction with S&F teledermatology, 
referring providers provided varied feedback (Bowns et al., 2006; Collins et al., 2004; 
Weinstock et al., 2002; Whited et al., 2004). Many referring providers report that they 
improved their therapeutic and diagnostic ability due to regular feedback and interactions 
with the dermatologist (van den Akker et al., 2001).  From the referring providers’ perspective, 
some dissatisfaction with the S&F teledermatology process stemmed from the additional time 
and effort required for relaying the diagnoses to patients, prescribing the medications, or 
performing procedures (Bowns et al., 2006; Collins et al., 2004; Kvedar et al., 1999).  
Fewer studies have evaluated satisfaction of dermatologists who practice teledermatology. 
While most dermatologists practicing teledermatology reported increased satisfaction 
(Whited, 2010), many report reduced confidence in their diagnoses (Bowns et al., 2006; Pak 
et al., 1999; Whited et al., 2004). 
2.2 Economic considerations of store-and-forward teledermatology 
We begin discussion of the economic aspects of S&F teledermatology with a brief review of 
common types of economic analysis. Three commonly used methods are cost minimization 
analysis, cost-effectiveness analysis, and cost-benefit analysis (Davalos et al., 2009). Cost-
minimization analysis is a type of cost analysis that evaluates two systems that produce 
equivalent outcomes.  Cost-effectiveness analysis compares monetary costs (cost) in the 
context of outcomes (effectiveness). However, this type of analysis generally considers only 
one outcomes measure. In comparison, cost-benefit analysis considers multiple economic 
costs as well as varied benefits within a system, and it generally includes multiple outcomes 
measures. Cost-benefit analyses are generally considered the most comprehensive type of 
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economic analyses. Further information regarding economic evaluation metrics may be 
found in Davalos et al. (Davalos et al., 2009).  
Literature shows that S&F teledermatology is generally economically viable (Table 3). While 
studies differed in their economic perspective and modality of S&F teledermatology 
delivery (e.g. triage, consultation, versus provision of care), analyses have generally 
established that S&F teledermatology offers a cost-effective means of providing 
dermatologic care especially for those living in geographically isolated communities or 
medically underserved communities (Pak et al., 2009; Whited et al., 2003). For example, in a 
cost-minimization analysis that adopted the perspective of the U.S. Department of Defense, 
Pak et al. concluded that the use of teleconsultations through S&F technology reduced 
overall costs compared to conventional care (Pak et al., 2009).  
Similarly, Whited et al. performed a cost analysis of a consultative model using S&F 
technology from the perspective of the U.S. Department of Veterans Affairs (Whited et al., 
2003). The authors found that teleconsultations are $15 more costly per patient compared to 
face-to-face consultation. In this study, effectiveness was defined as time-to-specialist 
evaluation. They found that having teledermatology consultations resulted in shorter time-
to-specialist evaluation and was overall more cost-effective. Further analyses showed that, 
from a societal perspective, S&F teleconsultations would be even less costly after accounting 
for patients’ travel time and productivity lost through face-to-face care (Whited et al., 2003).  
When S&F teledermatology was used as a primary method for triaging cases appropriate 
face-to-face encounters, researchers found that this was an economically viable means for 
prioritizing patients requiring dermatologic care (Ferrandiz et al., 2008; Moreno-Ramirez et 
al., 2009). By comparing S&F teledermatology and conventional referrals to a skin cancer 
clinic in Spain, Moreno-Ramirez et al. conducted a cost-identification and cost-effectiveness 
analysis from a societal perspective (Moreno-Ramirez et al., 2009). The investigators 
assessed costs associated with travel, lost-productivity, and healthcare delivery. 
Effectiveness was defined as the wait-time to in-person consultation after the referral. The 
authors found that teledermatology triage was more cost-effective; specifically, 
teledermatology yielded cost-savings of €49.59 per patient compared with conventional 
face-to-face care (Moreno-Ramirez et al., 2009). These findings were corroborated by another 
cost-effectiveness study in Spain, where the investigators found that the use of 
teledermatology saved €122.02 compared to conventional care (Ferrandiz et al., 2008).  
 
Reference Type of Analysis Teleconsultation Conventional Perspective 
Provision of Care 
(Pak et al., 2009) Cost-minimization $340 / patient $372 / patient 
Department of 
Defense 
(Whited et al., 2003) Cost / Cost-effectiveness $36.40 / patient 
$21.40 / 
patient 
Department of 
Veterans 
Affairs 
Triage 
(Moreno-Ramirez et 
al., 2009) 
Cost-identification / 
Cost-effectiveness 
€79.78 / patient 
€129.37 / 
patient 
Societal 
(Ferrandiz et al., 
2008) 
Cost / Cost-effectiveness €156.40 / patient 
€278.42 / 
patient 
Societal 
$ - US dollars; € - euros 
Table 4. Economic Analyses of Store-and-Forward Teledermatology 
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3. Live, Interactive Teledermatology 
Live, interactive teledermatology involves synchronous interaction between the specialist 
and patient (Goldyne & Armstrong, 2010). Via videoconferencing or web-conferencing, the 
specialist obtains a clinical history, examines the patient in real-time, and communicates 
recommendations to the patient and the primary care provider (Wootton et al., 2000).  
3.1 Outcomes measures of Live, Interactive Teledermatology 
We will consider the same outcomes measures for LI teledermatology as we did for S&F 
teledermatology: diagnostic accuracy, diagnostic reliability, clinical outcomes, and 
satisfaction. 
3.1.1 Diagnostic accuracy of LI Teledermatology 
Studies comparing diagnostic accuracy of LI teledermatology to pathologic diagnosis are 
not currently available. Studies comparing diagnoses between LI teledermatology and in-
person consultation generally show diagnostic agreement, and will be discussed further 
under diagnostic reliability. 
3.1.2 Diagnostic reliability of Live, Interactive Teledermatology 
Studies of intraobserver reliability between LI teledermatology and in-person consultation 
show complete diagnostic agreement in 59-75% of cases, and partial agreement in 76-87% of 
cases (Table 5).  
 
Reference 
Complete Diagnostic 
Agreement 
Partial Diagnostic 
Agreement 
(Loane et al., 1998b) .71 .87 
(Gilmour et al., 1998) .59 .76 
(Oakley et al., 1997) .75 .82 
Table 5. Intraobserver Reliability for LI Teledermatology 
Interobserver reliability between LI teledermatology and in-person consultation ranges from 
54-80% for complete diagnostic agreement, and 79-99% for partial agreement (Table 6). A 
review of aggregate data indicates that complete diagnostic agreement is 70%, while partial 
diagnostic agreement is 84% (Romero et al., 2008). 
 
Reference 
Complete Diagnostic 
Agreement 
Partial Diagnostic 
Agreement 
(Nordal et al., 2001) .72 .86 
(Phillips et al., 1998) .59 - 
(Loane et al., 1998b) .60 .76 
(Lowitt et al., 1998) .80 - 
(Gilmour et al., 1998) .54 .80 
(Lesher et al., 1998) .78 .99 
(Phillips et al., 1997) .77 - 
Table 6. Interobserver Reliability for LI Teledermatology 
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3.1.3 Clinical outcomes for LI Teledermatology 
One study evaluated clinical outcomes for LI teledermatology compared to conventional 
care. In a retrospective analysis of patients who had two or more teledermatology 
consultations, Marcin et al. found that diagnosis, treatment, and patient improvement data 
for the teledermatology patients were consistent with existing literature regarding 
conventional care (Marcin et al., 2005). 
Intermediate outcomes measures include (1) preventable clinic visits and (2) time for 
completion of consultation. Similar to the S&F modality, LI teledermatology can prevent 
unnecessary clinic visits. Studies found that 44.4-82% of clinic visits could be avoided 
through the use of LI teledermatology (Whited, 2010).  
LI teledermatology can decrease total time necessary to complete a consultation visit from 
the patient’s perspective. For example, researchers in New Zealand found that, compared to 
a clinic visit, the use of LI teledermatology saved patients an average of 3.45 hours of time, 
primarily due to reduced traveling time (Oakley et al., 2000). However, LI teledermatology 
does not necessarily reduce consult time for the dermatologist (Loane et al., 1999, 2001b; 
Oakley et al., 2000). 
3.1.4 Satisfaction with Live, Interactive Teledermatology 
As stated previously, satisfaction in teledermatology is categorized into patient satisfaction, 
referring provider satisfaction, and dermatologist satisfaction.  Patients reported that they 
were equally satisfied with LI teledermatology and conventional care and had no strong 
preference for one modality over another (Whited, 2010). Some patients reported initial 
discomfort due to the presence of camera (Gilmour et al., 1998; Loane et al., 1998a). 
Relatively few studies evaluated referring provider satisfaction in LI teledermatology. While 
there was some dissatisfaction associated with technical difficulties, most referring 
providers report being satisfied with the LI teledermatology (Gilmour et al., 1998; Jones et 
al., 1996). 
Similar to dermatologists who practice S&F teledermatology, dermatologists who practice LI 
teledermatology report being satisfied with practicing LI teledermatology. However, when 
compared to in-person consultation, dermatologists expressed lower confidence in their 
diagnoses (Artiles Sanchez et al., 2004; Lowitt et al., 1998). 
3.2 Economic considerations of Live, Interactive Teledermatology 
Economic analyses of LI teledermatology yielded mixed conclusions regarding its economic 
sustainability. While some studies have shown LI teledermatology to be cost-effective, 
others suggested that it may be more costly than conventional care. In a cost-minimization 
analysis from a societal perspective, authors from New Zealand found that teledermatology 
consultations using LI technology appeared less costly than that of face-to-face care, 
especially when patients have longer travel distances (Loane et al., 2001b). In another cost-
minimization study of LI teledermatology in the U.S., investigators found that consultative 
teledermatology using LI technology also appears to be less costly than face-to-face care 
from a provider perspective (Armstrong et al., 2007).  
In a cost-benefit analysis from the societal perspective, Wootton et al. found that a LI 
teleconsultation system in the United Kingdom was more costly than face-to-face care. 
Sensitivity analyses showed that LI teledermatology consultations could be a less costly 
alternative if patients travelled longer distances for in-person consultations and incurred 
greater lost-productivity costs (Wootton et al., 2000).  
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Reference Type of Analysis Teleconsultation Conventional Perspective 
(Dekio et al., 
2010) 
Cost-effectiveness ¥26,040 / week ¥60,500 / week Societal 
(Armstrong et 
al., 2007) 
Cost-minimization $274 / hour $346 / hour 
Healthcare 
provider 
(Loane et al., 
2001b) 
Cost-minimization 
NZ$279.23 / 
patient 
NZ$283.79 / 
patient 
Societal 
(Loane et al., 
2001a) 
Cost-benefit £146.48 / patient £47.13 / patient Urban Societal 
(Loane et al., 
2001a) 
Cost-benefit £180.22 / patient £48.77 / patient Rural Societal 
(Wootton et al., 
2000) 
Cost-benefit £132.10 / patient £48.73 / patient Societal 
(Lamminen et 
al., 2000) 
Cost 
FM 18,627 (total 
cost) 
FM 18,034 (total 
cost) 
Societal 
(Bergmo, 2000) Cost-minimization 
NKr 470,780 (total 
cost) 
NKr 1,635,075 
(total cost) 
Healthcare 
provider 
(Chan et al., 
2000) 
Cost / Cost-
effectiveness 
HK$57.7 / patient 
HK$322.8 / 
patient 
Healthcare 
provider 
(Burgiss et al., 
1997) 
Cost $141 / patient $294 / patient Societal 
¥ - yen; € - euros; $ - US dollars; NZ$ - New Zealand dollars; £ - pounds; FM – Finnish marks; NKr – 
Norwegian kroners; HK$ - Hong Kong dollars 
Table 7. Economic Analyses of Live, Interactive Teledermatology 
4. Comparison of store-and-forward and Live, Interactive Teledermatology 
Approximately 42% of the United States population lives in medically underserved areas 
(Suneja et al., 2001). Both S&F and LI teledermatology can increase access to specialty care 
especially for populations living in rural or medically underserved areas (Hailey, 2005; 
Kailasam et al., 2010; Pak et al., 2007; Vallejos et al., 2009).  
S&F and LI teledermatology present distinct advantages. S&F teledermatology appears to be 
very cost-effective. Specifically, compared to LI teledermatology, S&F teledermatology 
requires less equipment or technology costs (Pak, 2008; Watson, 2009). The requirements for 
administrative support and overhead also appear to be less for S&F teledermatology. 
Finally, the asynchronous nature of S&F modality affords greater scheduling flexibility for 
patients and dermatologists since coordinated appointments with specialists are not 
required (Finch et al., 2007; Watson, 2009). LI teledermatology, on the other hand, more 
closely mirrors a conventional face-to-face consultation because the specialist can interact 
with patients and a referring provider in real-time.   
S&F and LI teledermatology have their respective disadvantages as well.  In S&F 
teledermatology, because the ability of the dermatologist to diagnose and provide useful 
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recommendations depends solely on the quality of images and clinical history, suboptimal 
images or incomplete clinical history can be frustrating for the dermatologist.  Furthermore, 
S&F teledermatology does not allow the development of a patient-dermatologist 
relationship compared to LI teledermatology (Grenier et al., 2009; Onor & Misan, 2005). LI 
teledermatology presents alternative challenges in terms of scheduling, coordination, and 
costs.  
Given the unique benefits that each modality offers, some providers have recently started to 
employ a hybrid model. In the hybrid model, the clinical encounters are conducted via 
videoconferencing or webconferencing, and the dermatologist reviews static digital images 
that were acquired by a digital camera prior to the encounter and sent to them during the 
encounter. Current research efforts are investigating the relative effectiveness of such hybrid 
systems (Baba et al., 2005; Romero et al., 2010). For example, Baba et al. found that a hybrid 
modality increased diagnostic accuracy by 7-9%, compared to S&F teledermatology alone 
(Baba et al., 2005).  
5. Novel classification teledermatology based on healthcare delivery models  
To date, teledermatology has been categorized by the technology it uses--S&F and LI 
technology. An alternative model to frame teledermatology is based on the type of 
healthcare delivery. Specifically, independent of the type of technology employed, we can 
arrange teledermatology delivery into (1) triage, (2) consultative, and (3) direct-care models. 
This technology-independent, healthcare delivery-based framework is accessible to policy 
makers and other stakeholders involved in health policy. 
5.1 Triage model 
In the triage model, all dermatology referrals are first seen through teledermatology. A 
specialist reviews the cases rapidly with the goal of prioritizing which patients are suitable 
for in-person evaluation. The triage model prioritizes patients based on the severity and 
urgency of their skin condition.  This modality has been primarily practiced in Europe in 
prioritization patients with cutaneous malignancies (Ferrandiz et al., 2007; Moreno-Ramirez 
et al., 2007). 
5.2 Consultative model 
In the consultative model, the referring providers decide which dermatology referrals are 
appropriate for teledermatology evaluation.  From the dermatologist’s perspective, the 
primary goal of the consultative model is to provide detailed and useful recommendations 
to the primary care provider. In this healthcare delivery model, the dermatologist reviews 
the cases via either S&F or LI technology and provides detailed recommendations to the 
primary care provider. The primary care provider assumes responsibility for 
communicating with the patient and carrying out the recommendation plans. The 
consultative model is currently the most common model in the United States (Goldyne & 
Armstrong, 2010).  
5.3 Direct-care model 
In the direct-care model, the dermatologist assumes the responsibility of communicating 
and treating the patient. This model differs significantly from the triage or consultative 
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model in that the dermatologist is responsible for caring for the patient.  The provision of 
direct care includes evaluation, communicating the treatment plan to the patient, writing 
prescriptions, carrying out laboratory evaluations, and monitoring disease progression.  
The direct-care model has generally been practiced using S&F technology and in research 
settings (Chambers et al., 2010; Parsi et al., 2010; Watson et al., 2010). 
6. Conclusion 
As healthcare delivery becomes more patient-centered and distance-independent (Hibbard, 
2004; Hogarth et al., 2010; Robinson et al., 2011), proper application of teledermatology 
offers a versatile means of providing high quality care to patients in their own communities.  
Teledermatology can be used in various healthcare delivery modalities, including triage, 
consultation, and direct care. 
In addition to gathering the support of healthcare workers and patients for these newer 
models of healthcare delivery, those who work at the forefront of telemedicine need to also 
advocate for policy changes and technological innovations to continually improve the 
quality and experience of telemedicine.  It is likely that the cost of technology will decline as 
the reliability and user-interface of technology continually improve.  In this healthcare 
environment, innovations in teledermatology serve as examples for emerging paradigms in 
healthcare delivery. 
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